Vaccine Interval Spacing

About Vaccine Interval Spacing

Vaccine dosing intervals affect immunogenicity and protection. Longer intervals between vaccine doses generally produce stronger immune responses. The UK delayed the second Pfizer COVID dose from 3 weeks to 12 weeks to maximize first dose coverage. Pfizer objected, stating that the 3 week interval was tested in clinical trials. WHO advisers later accepted longer intervals in some circumstances. Studies showed that extending the interval improved immune responses. For MMR, a second dose is included in schedules partly to protect children who did not respond to the first; timing varies by country. For HPV, longer intervals between doses have been associated with stronger antibody responses. The timing of the first HPV dose may affect long term protection. Some countries have adopted single dose HPV vaccination based on interval research. Vaccine interval optimization continues to evolve based on immunological research.